VACCINE-BASED IMMUNOTHERAPY OF CHOROIDAL NEOVASCULARISATION

摘要

FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to vaccines for treating and/or preventing the diseases caused by choroidal neovascularisation (neovascular maculopathy), which contain peptides derived from VEGFR2, as the active ingredient.EFFECT: vaccination with the use of this peptide as an antigen is effective to inhibit choroidal neovascularisation.8 cl, 4 dwg